The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review
- PMID: 33664685
- PMCID: PMC7920961
- DOI: 10.3389/fpsyt.2021.630247
The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review
Abstract
Background: Cannabis is known to have a broad range of effects on behavior, including experiencing a "high" and tranquility/relaxation. However, there are several adverse behavioral sequalae that can arise from cannabis use, depending on frequency of use, potency (e.g., THC content), age of onset, and cumulative exposure. This systematic review examined evidence for cannabis-related adverse behavioral sequalae in otherwise healthy human subjects. Methods: Following PRISMA guidelines, we conducted a systematic review of cross-sectional and longitudinal studies from 1990 to 2020 that identified cannabis-related adverse behavioral outcomes in subjects without psychiatric and medical co-morbidities from PubMed and PsychInfo searches. Key search terms included "cannabis" OR "tetrahydrocannabinol" OR "cannabidiol" OR "marijuana" AND "anxiety" OR "depression" OR "psychosis" OR "schizophrenia" "OR "IQ" OR "memory" OR "attention" OR "impulsivity" OR "cognition" OR "education" OR "occupation". Results: Our search detected a total of 2,870 studies, from which we extracted 124 relevant studies from the literature on cannabis effects in the non-clinical population. Effects of cannabis on several behavioral sequelae including cognition, motivation, impulsivity, mood, anxiety, psychosis intelligence, and psychosocial functioning were identified. The preponderance of the evidence suggests that frequency of cannabis use, THC (but not CBD) content, age of onset, and cumulative cannabis exposure can all contribute to these adverse outcomes in individuals without a pre-existing medical condition or psychiatric disorder. The strongest evidence for the negative effects of cannabis are for psychosis and psychosocial functioning. Conclusions: Although more research is needed to determine risk factors for development of adverse behavioral sequelae of cannabis use, these findings underline the importance of understanding vulnerability to the adverse effects of cannabis, which has implications for prevention and treatment of problematic cannabis use.
Keywords: anxiety; cannabis; cognition; healthy subjects; intelligence; mood; motivation; psychosis.
Copyright © 2021 Sorkhou, Bedder and George.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review.Cureus. 2020 Jul 21;12(7):e9309. doi: 10.7759/cureus.9309. Cureus. 2020. PMID: 32839678 Free PMC article. Review.
-
The Impact of Cannabidiol on Human Brain Function: A Systematic Review.Front Pharmacol. 2021 Jan 21;11:618184. doi: 10.3389/fphar.2020.618184. eCollection 2020. Front Pharmacol. 2021. PMID: 33551817 Free PMC article. Review.
-
Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.J Am Acad Child Adolesc Psychiatry. 2017 Mar;56(3):214-225. doi: 10.1016/j.jaac.2016.12.014. Epub 2016 Dec 29. J Am Acad Child Adolesc Psychiatry. 2017. PMID: 28219487 Review.
-
The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.Schizophr Bull. 2018 Jan 13;44(1):46-53. doi: 10.1093/schbul/sbx105. Schizophr Bull. 2018. PMID: 29083450 Free PMC article. Review.
-
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.Neuropsychopharmacology. 2018 Jan;43(1):142-154. doi: 10.1038/npp.2017.209. Epub 2017 Sep 6. Neuropsychopharmacology. 2018. PMID: 28875990 Free PMC article. Review.
Cited by
-
Cannabis use and mood disorders: a systematic review.Front Public Health. 2024 Apr 9;12:1346207. doi: 10.3389/fpubh.2024.1346207. eCollection 2024. Front Public Health. 2024. PMID: 38655516 Free PMC article.
-
Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism.Biol Psychiatry Glob Open Sci. 2022 Jul 30;3(3):550-566. doi: 10.1016/j.bpsgos.2022.07.003. eCollection 2023 Jul. Biol Psychiatry Glob Open Sci. 2022. PMID: 37519471 Free PMC article.
-
Comparing Cannabis Use for Pain to Use for Other Reasons in Primary Care Patients.J Am Board Fam Med. 2024 Jan 5;36(6):996-1007. doi: 10.3122/jabfm.2023.230163R1. J Am Board Fam Med. 2024. PMID: 37907351 Free PMC article.
-
Cannabichromene from full-spectrum hemp extract exerts acute anti-seizure effects through allosteric activation of GABAA receptors.Fundam Res. 2024 Apr 20;4(6):1357-1364. doi: 10.1016/j.fmre.2023.05.023. eCollection 2024 Nov. Fundam Res. 2024. PMID: 39734535 Free PMC article.
-
Cannabis use following bariatric surgery is associated with anxiety and maladaptive eating.Surg Obes Relat Dis. 2024 Jan;20(1):91-97. doi: 10.1016/j.soard.2023.09.009. Epub 2023 Sep 11. Surg Obes Relat Dis. 2024. PMID: 37863791 Free PMC article.
References
-
- Abuse S, Administration MHS. Key Substance Use and Mental Health Indicators in the United States: Results From the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Substance Abuse and Mental Health Services Administration (2017).
-
- United Nations Office on Drugs and Crime .World Drug Report. Executive Summary. Conclusions and Policy Implications (2018).
-
- MacKay R, Phillips K, Tiedemann M. Bill C-45: An Act Respecting Cannabis and to Amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Library of Parliament (2018).
Publication types
LinkOut - more resources
Full Text Sources
